Connection
John Arcaroli to Vascular Endothelial Growth Factor Receptor-2
This is a "connection" page, showing publications John Arcaroli has written about Vascular Endothelial Growth Factor Receptor-2.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.442 |
|
|
|
-
Song EK, Tai WM, Messersmith WA, Bagby S, Purkey A, Quackenbush KS, Pitts TM, Wang G, Blatchford P, Yahn R, Kaplan J, Tan AC, Atreya CE, Eckhardt G, Kelley RK, Venook A, Kwak EL, Ryan D, Arcaroli JJ. Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model. Int J Cancer. 2015 Apr 15; 136(8):1967-75.
Score: 0.442